Tandem Diabetes Care Inc (TNDM) stock
TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3024% below fair value
$17.06−1.42 (-7.68%)
Close on Nov 17, 2026Market cap $1.19BP/E –Yield –
Tandem Diabetes Care operating margin
Operating margin is operating income as a percentage of revenue.
Tandem Diabetes Care's operating margin for the twelve months ending Jun 30, 2026 was -4.4%. For fiscal 2025 it was -18.5%, against -10.5% the year before. The highest annual figure on record is 3.2% in fiscal 2021.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -18.5% | −7.9 |
| FY2024 | Dec 31, 2024 | -10.5% | +20.6 |
| FY2023 | Dec 31, 2023 | -31.2% | −19.6 |
| FY2022 | Dec 31, 2022 | -11.6% | −14.8 |
| FY2021 | Dec 31, 2021 | 3.2% | +4.8 |
| FY2020 | Dec 31, 2020 | -1.6% | +3.0 |
| FY2019 | Dec 31, 2019 | -4.6% | +19.7 |
| FY2018 | Dec 31, 2018 | -24.3% | +34.2 |
| FY2017 | Dec 31, 2017 | -58.5% | +34.1 |
| FY2016 | Dec 31, 2016 | -92.6% | +2.1 |
| FY2015 | Dec 31, 2015 | -94.7% | +57.5 |
| FY2014 | Dec 31, 2014 | -152.2% | +18.2 |
| FY2013 | Dec 31, 2013 | -170.4% | +1164.9 |
| FY2012 | Dec 31, 2012 | -1335.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -5.4% | +16.1 |
| Q1 FY2026 | Mar 31, 2026 | -7.1% | +44.5 |
| Q4 FY2025 | Dec 31, 2025 | 2.9% | +3.1 |
| Q3 FY2025 | Sep 30, 2025 | -9.2% | +1.5 |
| Q2 FY2025 | Jun 30, 2025 | -21.5% | −7.7 |
| Q1 FY2025 | Mar 31, 2025 | -51.6% | −29.8 |
| Q4 FY2024 | Dec 31, 2024 | -0.2% | +17.6 |
| Q3 FY2024 | Sep 30, 2024 | -10.7% | +6.3 |
| Q2 FY2024 | Jun 30, 2024 | -13.9% | +5.9 |
| Q1 FY2024 | Mar 31, 2024 | -21.7% | +53.7 |
| Q4 FY2023 | Dec 31, 2023 | -17.8% | −9.8 |
| Q3 FY2023 | Sep 30, 2023 | -17.0% | +6.2 |
| Q2 FY2023 | Jun 30, 2023 | -19.8% | −13.7 |
| Q1 FY2023 | Mar 31, 2023 | -75.5% | −66.7 |
| Q4 FY2022 | Dec 31, 2022 | -8.1% | −14.1 |
| Q3 FY2022 | Sep 30, 2022 | -23.2% | −27.5 |
| Q2 FY2022 | Jun 30, 2022 | -6.1% | −9.3 |
| Q1 FY2022 | Mar 31, 2022 | -8.7% | −6.4 |
| Q4 FY2021 | Dec 31, 2021 | 6.1% | −5.0 |
| Q3 FY2021 | Sep 30, 2021 | 4.3% | +5.1 |
| Q2 FY2021 | Jun 30, 2021 | 3.2% | +14.2 |
| Q1 FY2021 | Mar 31, 2021 | -2.3% | +11.6 |
| Q4 FY2020 | Dec 31, 2020 | 11.1% | +9.1 |
| Q3 FY2020 | Sep 30, 2020 | -0.8% | +5.5 |
| Q2 FY2020 | Jun 30, 2020 | -11.0% | −9.0 |
| Q1 FY2020 | Mar 31, 2020 | -13.9% | +2.8 |
| Q4 FY2019 | Dec 31, 2019 | 2.0% | +1.2 |
| Q3 FY2019 | Sep 30, 2019 | -6.3% | +27.6 |
| Q2 FY2019 | Jun 30, 2019 | -2.0% | +39.0 |
| Q1 FY2019 | Mar 31, 2019 | -16.7% | +40.1 |
| Q4 FY2018 | Dec 31, 2018 | 0.7% | +24.5 |
| Q3 FY2018 | Sep 30, 2018 | -34.0% | +14.8 |
| Q2 FY2018 | Jun 30, 2018 | -41.0% | +47.9 |
| Q1 FY2018 | Mar 31, 2018 | -56.8% | +55.1 |
| Q4 FY2017 | Dec 31, 2017 | -23.8% | +22.4 |
| Q3 FY2017 | Sep 30, 2017 | -48.8% | +182.4 |
| Q2 FY2017 | Jun 30, 2017 | -88.9% | – |
| Q1 FY2017 | Mar 31, 2017 | -111.9% | – |
| Q4 FY2016 | Dec 31, 2016 | -46.2% | – |
| Q3 FY2016 | Sep 30, 2016 | -231.1% | – |
See a number that looks wrong?